비교리스트

 카트 문의
시장보고서
상품코드
1349440

수장다한증 치료 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2023-2031년)

Palmar Hyperhidrosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 130 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수장다한증 치료 시장 - 보고서 범위

세계의 수장다한증 치료 시장에 관한 TMR의 보고서는 과거와 현재의 성장 동향 및 2023년부터 2031년 예측기간 동안 시장 지표의 귀중한 인사이트를 얻을 수 있는 기회를 연구하고 있습니다. 이 보고서에서는 2023년을 기준 연도, 2031년을 예측 연도로서 2017년부터 2031년까지 수장다한증 치료 세계 시장 매출을 제공합니다. 또한 2023년부터 2031년까지의 세계 수장다한증 치료 시장 연평균 성장률(CAGR %)도 제공합니다.

이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서는 조사 활동의 대부분이 이루어지고, 애널리스트가 주요 오피니언 리더, 업계 리더, 오피니언 메이커와의 인터뷰를 실시했습니다. 2차 조사에는 수장다한증 치료 시장을 이해하기 위해 주요 기업의 제품 문헌, 연차 보고서, 프레스 릴리스 및 관련 문서를 참조하는 것이 포함되어 있었습니다.

시장 현황
2023년 시장 가치 3억 1,810만 달러
2031년 시장 가치 4억 2,320만 달러
CAGR3.3%

이 보고서는 세계의 수장다한증 치료 시장 경쟁 상황을 자세히 살펴봅니다. 세계의 수장다한증 치료 시장에서 활동하는 주요 기업이 확인되었으며, 이들 각각이 다양한 속성의 관점에서 프로파일링됩니다. 기업 개요, 재무 상황, 최근의 동향, SWOT는 이 보고서에서 소개되고 있는 세계의 수장다한증 치료 시장 기업의 속성입니다.

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

  • 서론
  • 개요
  • 시장 역학
  • 세계 시장 분석과 예측, 2017-2031년
  • Porter's Five Forces 분석

제5장 주요 인사이트

  • 수장다한증 : 세계 주요 국가의 질환 유병률
  • 개요 : 치료 선택사항 진보
  • 규제 시나리오
  • COVID-19 팬데믹이 업계에 미치는 영향

제6장 세계 시장 분석과 예측 : 치료 유형별

  • 서론과 정의
  • 주요 발견과 개발
  • 시장 가치 예측 : 치료 유형별, 2017-2031
    • 보톡스(보툴리눔톡신)
    • 의학요법
    • 이온도입
    • 내시경적 흉부 교감신경 절제술(ETS) 수술
  • 시장 매력 분석 : 치료 유형별

제7장 세계 시장 분석과 예측 : 최종사용자별

  • 서론과 정의
  • 주요 발견과 개발
  • 시장 가치 예측 : 최종사용자별, 2017-2031
    • 병원
    • 피부과 클리닉
    • 에스테틱 센터
    • 기타(재택의료 설정 등)
  • 시장 매력 분석 : 최종사용자별

제8장 세계 시장 분석과 예측 : 지역별

  • 주요 조사 결과
  • 시장 가치 예측 : 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장 매력 분석 : 지역별

제9장 북미 시장 분석과 예측

제10장 유럽 시장 분석과 예측

제11장 아시아태평양 시장 분석과 예측

제12장 라틴아메리카 시장 분석과 예측

제13장 중동 및 아프리카 시장 분석과 예측

제14장 경쟁 상황

  • 시장 진출 기업 - 경쟁 매트릭스(기업 계층 및 규모별)
  • 시장 점유율 분석 : 기업별, 2022년
  • 기업 개요
    • AbbVie, Inc.
    • Eli Lilly and Company
    • TheraVida, Inc.
    • Person &Covey, Inc.
    • Hugel, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Avanor Healthcare Ltd
    • Fresh Tracks Therapeutics, Inc.
    • Kaken Pharmaceutical Co., Ltd.
KSM 23.10.11

Palmar Hyperhidrosis Treatment Market - Scope of Report

TMR's report on the global palmar hyperhidrosis treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global palmar hyperhidrosis treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global palmar hyperhidrosis treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the palmar hyperhidrosis treatment market.

Market Snapshot
Market Value in 2023US$ 318.1 Mn
Market Value in 2031US$ 423.2 Mn
CAGR3.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global palmar hyperhidrosis treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global palmar hyperhidrosis treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global palmar hyperhidrosis treatment market.

The report delves into the competitive landscape of the global palmar hyperhidrosis treatment market. Key players operating in the global palmar hyperhidrosis treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global palmar hyperhidrosis treatment market profiled in this report.

Key Questions Answered in Global Palmar Hyperhidrosis Treatment Market Report:

  • What is the sales/revenue generated by palmar hyperhidrosis treatment across all regions during the forecast period?
  • What are the opportunities in the global palmar hyperhidrosis treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Palmar Hyperhidrosis Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global palmar hyperhidrosis treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global palmar hyperhidrosis treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global palmar hyperhidrosis treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Palmar Hyperhidrosis Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Palmar Hyperhidrosis Treatment Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Palmar Hyperhidrosis: Disease Prevalence Rate globally with key countries
  • 5.2. Overview: Advancements in Treatment Options
  • 5.3. Regulatory Scenario
  • 5.4. COVID-19 Pandemics Impact on Industry

6. Global Palmar Hyperhidrosis Treatment Market Analysis and Forecast, by Treatment Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Treatment Type, 2017-2031
    • 6.3.1. Botox (Botulinum Toxin)
    • 6.3.2. Medical Therapy
    • 6.3.3. Iontophoresis
    • 6.3.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 6.4. Market Attractiveness Analysis, by Treatment Type

7. Global Palmar Hyperhidrosis Treatment Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Dermatology Clinics
    • 7.3.3. Aesthetic Centers
    • 7.3.4. Others (Homecare Settings, etc.)
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Palmar Hyperhidrosis Treatment Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Palmar Hyperhidrosis Treatment Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 9.2.1. Botox (Botulinum Toxin)
    • 9.2.2. Medical Therapy
    • 9.2.3. Iontophoresis
    • 9.2.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Dermatology Clinics
    • 9.3.3. Aesthetic Centers
    • 9.3.4. Others (Homecare Settings, etc.)
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Treatment Type
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Palmar Hyperhidrosis Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 10.2.1. Botox (Botulinum Toxin)
    • 10.2.2. Medical Therapy
    • 10.2.3. Iontophoresis
    • 10.2.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Dermatology Clinics
    • 10.3.3. Aesthetic Centers
    • 10.3.4. Others (Homecare Settings, etc.)
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Treatment Type
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Palmar Hyperhidrosis Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 11.2.1. Botox (Botulinum Toxin)
    • 11.2.2. Medical Therapy
    • 11.2.3. Iontophoresis
    • 11.2.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Dermatology Clinics
    • 11.3.3. Aesthetic Centers
    • 11.3.4. Others (Homecare Settings, etc.)
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Treatment Type
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Palmar Hyperhidrosis Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 12.2.1. Botox (Botulinum Toxin)
    • 12.2.2. Medical Therapy
    • 12.2.3. Iontophoresis
    • 12.2.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Hospitals
    • 12.3.2. Dermatology Clinics
    • 12.3.3. Aesthetic Centers
    • 12.3.4. Others (Homecare Settings, etc.)
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Treatment Type
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Palmar Hyperhidrosis Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 13.2.1. Botox (Botulinum Toxin)
    • 13.2.2. Medical Therapy
    • 13.2.3. Iontophoresis
    • 13.2.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Hospitals
    • 13.3.2. Dermatology Clinics
    • 13.3.3. Aesthetic Centers
    • 13.3.4. Others (Homecare Settings, etc.)
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Treatment Type
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2022
  • 14.3. Company Profiles
    • 14.3.1. AbbVie, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Eli Lilly and Company
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. TheraVida, Inc.
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Person & Covey, Inc.
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Hugel, Inc.
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Dr. Reddy's Laboratories Ltd.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Avanor Healthcare Ltd
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Fresh Tracks Therapeutics, Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Kaken Pharmaceutical Co., Ltd.
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제